1 / 15

Papillary Thyroid Microcarcinoma : A Report of Impact of Initial Therapy in 2035 Patients

Papillary Thyroid Microcarcinoma : A Report of Impact of Initial Therapy in 2035 Patients. Jeonghun Lee, Su Han Seo , Euy Young Soh Department of Surgery, Ajou University. Introduction. Introduction Papillary thyroid carcinoma ① accounts for up to 80% of thyroid cancer

boris-curry
Download Presentation

Papillary Thyroid Microcarcinoma : A Report of Impact of Initial Therapy in 2035 Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Papillary Thyroid Microcarcinoma: A Report of Impact of Initial Therapy in 2035 Patients Jeonghun Lee, Su Han Seo, Euy Young Soh Department of Surgery, Ajou University

  2. Introduction Introduction Papillary thyroid carcinoma ① accounts for up to 80% of thyroid cancer ② papillary microcarcinoma : 36~60% of papillary thyroid cancer Discrepancy of treatment strategies ① geographical discrepancy : Western vs. Japan a. total thyroidectomy vs. lobectomy b. therapeutic vs. prophylactic CCND c. radioiodine therapy ② temporal discrepancy : at Mayo Clinic (Hay et al) a. 1940~54 - most lobectomy and no RAI b. 1985~ - most total thyroidectomy and 50% RAI therapy

  3. Introduction Prognostic factors for recurrence - different among the institutions • Buffet et al ( Europ J endo 2012 ) : LN metastasis, multifocality, male, total size of multifocal tumor>20mm) • Kim TY et al ( BMC cancer 2008 ) : male, lateral cervical LN metastasis • Chow et al ( Cancer 2003 ) : multifocality, limited surgery • Hay et al ( Surgery 1992 ) : LN metastasis, limited surgery

  4. Purpose : To investigate the prognostic factors for recurrence in PTMC patients.

  5. Materials and Methods Periods : Jan.1994 ~ Oct. 2010 Patients : 2035 PTMC patients who underwent thyroidectomy at Ajou University Hospital Inclusion criteria ① papillary thyroid microcarcinoma ② underwent primary surgical therapy at Ajou University Hospital

  6. Materials and Methods • Strategy for papillary thyroid cancer at Ajou University Hospital ① Lobectomy : papillary thyroid caner < 1cm, no familial history, no capsular invasion, no multifocality and no LN metastasis. ② Central compartment LN dissection(CCND) : if malignancy on FNA cytology or frozen section biopsy  prophylactic CCND was performed ③ Lateral compartment LN dissection : therapeutic LN dissection

  7. Materials and Methods • Mean follow-up duration : 33.8 months WIFTC : wide invasive FTC, MIFTC : minimal invasive FTC MTC : medullary thyroid cancer, HCC : Hurthle cell cancer

  8. Clinicopathologicfeatures

  9. Univariate statistical analysis for recurrence

  10. Univariate statistical analysis for recurrence

  11. Univariate statistical analysis for recurrence RAI therapy 97.9% 74.3%

  12. Univariate statistical analysis for recurrence N stage 98.1% 92.6% 90.5% 67.3%

  13. Multivariate statistical analysis for recurrence

  14. Summary • Prognostic factors for recurrence ① Extent of thyroidectomy : no significant factor ② RAI therapy : no significant factor in multivariate analysis ③ N stage : only significant factor for recurrence in multivariate analysis - N1a : 2 riskier than N0 ( p= 0.01) - N1b : 6.7 riskier than N0 (p< 0.01) • Complication ① postoperative hoarseness : 1.9% ② permanent hypoparathyroidism : 4.5% (2.7%*~12%#) *Caliskan et al 2012 Endocrine J #Mitra et al 2011 J LaryngolOtol

  15. Conclusion • Limited thyroidectomy : maybe sufficient for initial surgery for PTMC patients • Prophylactic central LN dissection : can be performed for PTMC patients for predicting prognosis accurately, : however, performed by skilled surgeon because of higher incidence of permanent hypoparathyroidism • Limitation of study : short-term follow-up duration

More Related